One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia.
Cognitive rehabilitation is an effective intervention for addressing cognitive impairments in patients with schizophrenia. Previous research has shown that the early application of Cognitive Enhancement Therapy (CET) can improve neurocognitive and social-cognitive deficits in the early course of the disorder, and ultimately reduce the substantial functional disability that these patients experience. However, the lasting effects of CET on functional outcome in early course schizophrenia patients remain unknown. In this study, 58 patients in the early course of schizophrenia or schizoaffective disorder treated with 2 years of either CET or an Enriched Supportive Therapy (EST) control were followed-up 1 year after the completion of treatment to examine the durability of CET effects on functional outcome. At one-year post-treatment, a high (72%) retention rate was observed in both treatments. Results from intent-to-treat analyses employing linear mixed-effects models indicated that CET effects on functional outcome were broadly maintained one-year post-treatment, and that patients receiving CET continued to demonstrate highly significant differential functional benefits compared to patients treated with EST. These findings support the durability of CET effects on functional outcome in the early course of schizophrenia, and point to the potential of cognitive rehabilitation to have a lasting impact on the early trajectory of the disorder.
Eack
Shaun M
SM
School of Social Work, University of Pittsburgh, PA, USA. sme12@pitt.edu
Greenwald
Deborah P
DP
Hogarty
Susan S
SS
Keshavan
Matcheri S
MS
D000328:Adult; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009483:Neuropsychological Tests; D011237:Predictive Value of Tests; D012559:Schizophrenia / Q000503:physiopathology* / Q000534:rehabilitation*; D012565:Schizophrenic Psychology; D012917:Social Adjustment; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
Neuropsychology. 1998 Jul;12(3):426-45
9673998
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
16916889
Am J Psychiatry. 1997 Nov;154(11):1514-24
9356558
Arch Gen Psychiatry. 1974 Nov;31(5):609-18
4374156
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1873-8
18812206
Am J Psychiatry. 2004 Mar;161(3):473-9
14992973
Psychiatry Res. 1989 Mar;27(3):335-50
2710870
Am J Psychiatry. 2010 Feb;167(2):170-80
20008941
Schizophr Bull. 2010 Mar;36(2):370-80
18648021
Psychiatr Serv. 2009 Nov;60(11):1468-76
19880464
Dev Psychopathol. 1999 Summer;11(3):525-43
10532623
Arch Gen Psychiatry. 2004 Sep;61(9):866-76
15351765
Am J Psychiatry. 2007 Mar;164(3):437-41
17329468
Schizophr Bull. 2000;26(1):119-36
10755673
Acta Psychiatr Scand. 2005 Mar;111(3):193-201
15701103
Am J Psychiatry. 2008 Feb;165(2):203-13
18172019
Br J Psychiatry. 2007 May;190:421-7
17470957
Res Soc Work Pract. 2011 Jan 27;21(1):32-42
23885163
Arch Gen Psychiatry. 1994 Feb;51(2):124-31
7905258
Psychiatr Serv. 2006 Dec;57(12):1751-7
17158490
Psychol Bull. 1997 Jan;121(1):114-32
9000894
Am J Psychiatry. 2007 Dec;164(12):1791-802
18056233
Am J Psychiatry. 1999 Sep;156(9):1336-41
10484942
Schizophr Bull. 2008 May;34(3):544-54
17984299
Emotion. 2003 Mar;3(1):97-105
12899321